Inventor · Dossenheim, DE

Bernd Liepold

28Patents
6h-index
55Co-inventors
72Inventor score

Filing activity: Sep 18, 1999 → Jul 26, 2024

Most-cited inventions

PatentTitleAreaCited byStatus
US6599528B1 Mechanically stable pharmaceutical presentations form containing liquid or semisolid surface-active substances Human Necessities 33 Expired
US6599931B1 Test system for characterizing the compatibility of bioactive substances and polyvinylpyrrolidone Human Necessities 13 Expired
US8475842B2 Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one Human Necessities 13 Active
US9060986B2 Delivery system for sustained release of a calcium-channel blocking agent Human Necessities 13 Active
US8025899B2 Solid pharmaceutical dosage form Human Necessities 10 Active
US8268349B2 Solid pharmaceutical dosage form Human Necessities 9 Active
US11633396B2 Immediate release pharmaceutical formulation of 4-[3-(4- cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H- phthalazin-1-one Human Necessities 5 Active
US9333204B2 Solid antiviral dosage forms Human Necessities 5 Active
US8686026B2 Solid compositions Human Necessities 4 Active
US9744170B2 Solid antiviral dosage forms Human Necessities 3 Active
US8377952B2 Solid pharmaceutical dosage formulation Human Necessities 3 Active
US8399015B2 Solid pharmaceutical dosage form Human Necessities 2 Active
US8691878B2 Solid pharmaceutical dosage form Human Necessities 2 Active
US9642796B2 Pharmaceutical dosage form for oral administration of a bcl 2 family inhibitor Human Necessities 2 Active
US8333990B2 Solid pharmaceutical dosage form Human Necessities 1 Active
US9078921B2 Pharmaceutically acceptable solubilizing composition and pharmaceutical dosage form containing same Human Necessities 1 Active
US11975001B2 Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one Human Necessities 0 Active
US12178816B2 Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one Human Necessities 0 Active
US10463739B2 Solid retard formulations based on solid dispersions Human Necessities 0 Active
US10653625B2 Production of dosage forms comprising a solid dispersion of a microcrystalline agent Human Necessities 0 Active
US9402909B2 Pharmaceutical dosage form comprising polymeric carrier composition Human Necessities 0 Active
US8293374B2 Test system for evaluating the compatibility of biologically active substances with copolymers Emerging Cross-Sectional Technologies 0 Active
US9594073B2 Test solvent for evaluating the compatibility of biologically active substances and graft copolymers Chemistry; Metallurgy 0 Active
US9616130B2 Pharmaceutically acceptable solubilizing composition and pharmaceutical dosage form containing same Human Necessities 0 Active
US10105365B2 Solid antiviral dosage forms Human Necessities 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.